Pomalidomide Related Compounds & Impurities

Pomalidomide is a third-generation immunomodulatory drug (IMiD) that mediates cereblon-dependent protein degradation, used for relapsed/refractory multiple myeloma with stringent risk-management testing.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Pomalidomide reference standards, pharmacopeial and non-pharmacopeial Pomalidomide impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Pomalidomide-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Pomalidomide Impurity H
Pomalidomide Impurity B
Pomalidomide
Apremilast EP Impurity C
Pomalidomide Impurity 7
Pomalidomide Impurity 3
DL-Glutamine
Pomalidomide Impurity D
Pomalidomide Impurity 8
Pomalidomide Impurity 1
Pomalidomide Impurity 10
4-Nitrophthalic acid
4-Nitrophthalic Anhydride
Pomalidomide Impurity 20
Pomalidomide Impurity A
3-Aminophthalic acid hydrochloride
Pomalidomide Impurity E
Pomalidomide Impurity 2
Pomalidomide Impurity C
Pomalidomide Impurity 8
Pomalidomide Impurity 7
Pomalidomide Impurity 14
Pomalidomide Impurity 19
Pomalidomide Metabolite M16
(R)-Pomalidomide
(S)-Pomalidomide
7-amino-2-(2,6-dioxopiperidin-3-yl)-3a,4,5,6-tetrahydro-1H-isoindole-1,3(2H)-dione
Pomalidomide Impurity 23
3,6-dinitro phthalic acid
Pomalidomide Impurity 16
Pomalidomide Impurity 5
3-Aminophthalic Acid Hydrochloride Dihydrate
Pomalidomide Impurity 17
Pomalidomide Impurity 11
Pomalidomide Impurity 9
Pomalidomide Impurity 4
Pomalidomide Impurity 6
Pomalidomide Impurity 15
Pomalidomide Impurity 12
Pomalidomide Impurity 13

Metabolites

Pomalidomide Impurity J
Pomalidomide Metabolite M18

Isotope Labelled Compounds

Pomalidomide-d5
Pomalidomide D4
[13C5]-Pomalidomide